Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI
NCT01670526Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- Dec 2012
- Primary completion
- Jun 2016
- Modality
- Reversible Covalent Inhibitors, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of rivastigmine in traumatic brain injury (TBI), cognitive impairment, sponsored by VA Office of Research & Development. Started Dec 2012; status: completed.
02
Drugs
rivastigmine
03
Conditions
traumatic brain injury (TBI)cognitive impairment
Beyond the preview
Go deeper on NCT01670526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01670526.